Dr. Anna Pavlick on Dendritic Cells vs Montanide in Melanoma Patients in Remission

June 20, 2019
Anna Pavlick, MD
Anna Pavlick, MD

Cancer Network spoke with Anna Pavlick, MD, of NYU Langone Health, on the results of a phase II study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared with Montanide.

Cancer Network spoke with Anna Pavlick, MD, of NYU Langone Health, on the results of a phase II study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared with Montanide in melanoma patients in complete clinical remission. The data were presented at ASCO 2019.